Cite
HARVARD Citation
Ishii, H. et al. (2018). Dipeptidyl peptidase‐4 inhibitors as preferable oral hypoglycemic agents in terms of treatment satisfaction: Results from a multicenter, 12‐week, open label, randomized controlled study in Japan (PREFERENCE 4 study). Journal of diabetes investigation. 9 (1), pp. 137-145. [Online].